Follow
Ibai Goicoechea
Ibai Goicoechea
PhD Center for Applied Medical Research (CIMA)
Verified email at unav.es
Title
Cited by
Cited by
Year
New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies
E Larrea, C Sole, L Manterola, I Goicoechea, M Armesto, M Arestin, ...
International journal of molecular sciences 17 (5), 627, 2016
2612016
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard-and high-risk myeloma
I Goicoechea, N Puig, MT Cedena, L Burgos, L Cordón, MB Vidriales, ...
Blood, The Journal of the American Society of Hematology 137 (1), 49-60, 2021
942021
The circulating transcriptome as a source of non‐invasive cancer biomarkers: concepts and controversies of non‐coding and coding RNA in body fluids
M Fernandez‐Mercado, L Manterola, E Larrea, I Goicoechea, M Arestin, ...
Journal of cellular and molecular medicine 19 (10), 2307-2323, 2015
922015
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
C Perez, C Botta, A Zabaleta, N Puig, MT Cedena, I Goicoechea, ...
Blood, The Journal of the American Society of Hematology 136 (2), 199-209, 2020
892020
Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other …
CH Lawrie, E Larrea, G Larrinaga, I Goicoechea, M Arestin, ...
The Journal of Pathology 232 (1), 32-42, 2014
622014
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
JJ Garcés, M Simicek, M Vicari, L Brozova, L Burgos, R Bezdekova, ...
Leukemia 34 (2), 589-603, 2020
482020
MGMT expression predicts PARP-mediated resistance to temozolomide
O Erice, MP Smith, R White, I Goicoechea, J Barriuso, C Jones, ...
Molecular cancer therapeutics 14 (5), 1236-1246, 2015
462015
The circulating transcriptome as a source of biomarkers for melanoma
C Solé, D Tramonti, M Schramm, I Goicoechea, M Armesto, LI Hernandez, ...
Cancers 11 (1), 70, 2019
412019
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
C Maia, N Puig, MT Cedena, I Goicoechea, R Valdes-Mas, I Vazquez, ...
Blood, The Journal of the American Society of Hematology 135 (26), 2375-2387, 2020
352020
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
JJ Garcés, G Bretones, L Burgos, R Valdes-Mas, N Puig, MT Cedena, ...
Leukemia 34 (11), 3007-3018, 2020
312020
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
L Manterola, P Aguirre, E Larrea, M Arestín, A Gaafar, K Elorriaga, ...
Scientific Reports 8 (1), 6613, 2018
292018
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
S Rodriguez, J Celay, I Goicoechea, C Jimenez, C Botta, ...
Science Advances 8 (3), eabl4644, 2022
242022
Noncoding RNA expression and targeted next-generation sequencing distinguish tubulocystic renal cell carcinoma (TC-RCC) from other renal neoplasms
CH Lawrie, M Armesto, M Fernandez-Mercado, M Arestín, L Manterola, ...
The Journal of Molecular Diagnostics 20 (1), 34-45, 2018
242018
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
M Larrayoz, MJ Garcia-Barchino, J Celay, A Etxebeste, M Jimenez, ...
Nature Medicine 29 (3), 632-645, 2023
192023
A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma
C Guerrero, N Puig, MT Cedena, I Goicoechea, C Perez, JJ Garcés, ...
Clinical Cancer Research 28 (12), 2598-2609, 2022
192022
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
D Alameda, I Goicoechea, M Vicari, E Arriazu, A Nevone, S Rodriguez, ...
Blood, The Journal of the American Society of Hematology 138 (17), 1583-1589, 2021
182021
The urinary transcriptome as a source of biomarkers for prostate cancer
C Solé, I Goicoechea, A Gońi, M Schramm, M Armesto, M Arestin, ...
Cancers 12 (2), 513, 2020
162020
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer
R Argnani, P Marconi, I Volpi, E Bolanos, E Carro, C Ried, E Santamaria, ...
Liver International 31 (10), 1542-1553, 2011
162011
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis
A Nevone, M Girelli, S Mangiacavalli, B Paiva, P Milani, P Cascino, ...
Leukemia 36 (8), 2076-2085, 2022
152022
Single-cell characterization of the multiple myeloma (MM) immune microenvironment identifies CD27-negative T cells as potential source of tumor-reactive lymphocytes
C Botta, CP Ruiz, I Goicoechea, N Puig, MT Cedena, L Cordon, ...
Blood 134, 506, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20